Skip to content
Thursday, November 12, 2026
Clear Wage Express provides expert insights on payroll mana…

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Deal Over Information Concerns

Health funding illustration
The proposed US financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) over five years due to Washington's demand for confidential information.

This rejection came to light after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesperson later stated that the United States was requesting genetic material for research and commercial gain but was unwilling to guarantee the benefits from any future vaccines.

"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for further negotiations to secure a deal agreeable to all parties so the nation's critical HIV programme can be sustained.

Wider Background

This development comes after a comparable case in Kenya, where a court suspended a similar health funding agreement after concerns were filed about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.

Based on reports, Sixteen African countries have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this partnership would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data for a long time, without any equivalent guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.

"Put simply, our country would provide the basic resources for scientific discovery with no certainty that the end products would be available to our citizens should a future health crisis arise."

Sovereignty and International Frameworks

He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending frameworks previously set up through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.

"This framework is designed to ensure that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."

The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage ongoing discussions with our US partners on how subsequent collaboration could be arranged in a way that honours the independence and interests of both nations."

Health Experts Reaction

Medical experts said it acknowledged the government's concerns, but urged that talks must proceed considering a large portion of the nation's Aids initiatives relied on international support.

"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group said.

This impasse highlights the complex debate between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.

SG
The writer

Susan Gray

Maya is a certified HR consultant with over 10 years of experience in payroll systems and labor law compliance.

Clear Wage Express

Type to search articles.